Thesis Abstract

Abstract
Cancer remains a significant global health challenge, necessitating the development of innovative treatment strategies. The aim of this research is to explore the development of novel drug delivery systems for targeted cancer therapy. This thesis investigates the potential of targeted drug delivery systems to enhance the efficacy of cancer treatment while minimizing adverse effects on healthy tissues. The research methodology includes a comprehensive literature review to assess current drug delivery technologies, followed by the design and evaluation of novel drug delivery systems. The findings of this study contribute to the advancement of personalized medicine in oncology by providing insights into the development of targeted therapies for specific cancer types. The implications of this research are significant in improving patient outcomes and quality of life through the use of precision medicine approaches. Overall, this thesis highlights the importance of innovative drug delivery systems in revolutionizing cancer therapy and underscores the potential for targeted approaches to drive advancements in the field of oncology.

Thesis Overview

The project titled "Development of Novel Drug Delivery Systems for Targeted Cancer Therapy" aims to address the challenge of effectively delivering anticancer drugs to tumor sites while minimizing damage to healthy tissues. Traditional cancer treatments such as chemotherapy often result in significant side effects due to the inability to specifically target cancer cells. Therefore, the development of novel drug delivery systems that can enhance drug efficacy and reduce toxicity is crucial in improving cancer treatment outcomes. This research project focuses on exploring innovative drug delivery approaches that can selectively deliver therapeutic agents to cancer cells. By leveraging advancements in nanotechnology, targeted drug delivery systems can be designed to enhance drug accumulation at tumor sites through passive or active targeting mechanisms. The project will investigate the use of nanoparticles, liposomes, micelles, and other nano-carriers to encapsulate and deliver anticancer drugs with improved precision and efficiency. The research methodology will involve a combination of in vitro and in vivo studies to evaluate the performance of the developed drug delivery systems. In vitro experiments will assess the cellular uptake, cytotoxicity, and drug release kinetics of the nano-formulations using cancer cell lines. In vivo studies will involve animal models to investigate the pharmacokinetics, biodistribution, and therapeutic efficacy of the novel drug delivery systems in targeting cancerous tissues. The findings from this research project are expected to contribute valuable insights into the design and optimization of drug delivery systems for targeted cancer therapy. By enhancing the specificity and efficiency of drug delivery to tumor sites, these novel approaches have the potential to improve treatment outcomes, reduce side effects, and enhance patient quality of life. Overall, this project represents a significant step towards the development of personalized and effective cancer treatment strategies that can revolutionize the field of oncology.